Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,027,744
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
12,895,574
-
Shares change
-
-422,300
-
Total reported value, excl. options
-
$16,633,500
-
Value change
-
-$700,865
-
Number of buys
-
9
-
Number of sells
-
16
-
Price
-
$1.29
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) as of Q3 2023
As of 30 Sep 2023 NextCure, Inc. - Common Stock (NXTC) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,895,574 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Inc., Long Focus Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, and FEDERATED HERMES, INC..
This table shows 46 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.